A Study to Examine the Efficacy of the Arthritis Self Management Program

Alberta Bone and Joint Health Institute64 enrolled

Overview

This study will examine the efficacy of the Arthritis Self Managemnet Program (ASMP)and determine changes in health resource utilization after completeing the ASMP program.

This study will provide an analysis of the efficacy of the Arthritis Self Management Program (ASMP) using both patient administered questionnaires as well as the health utilization data maintained within the administrative databases at Alberta Health and Wellness. This study will also provide other information that has not yet been evaluated in other arthritis self management studies including co-morbidity data and other specific health related utilization information that has not yet been evaluated in other arthritis self management studies including co-morbidity data and other specific health related utilization information as it is recorded in administrative databases, will include a control group and will adjust for potential confounding variables such as sex, age, body mass index (BMI) and stage of disease.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

ECT

Masking

SINGLE

Enrollment

Conditions

Osteoarthritis

Interventions

Self-Management ProgramBEHAVIORAL

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * OA of the hip and/or knee * Patient is 18 years of age and over Exclusion Criteria: * a concurrent systemic inflammatory disease * Patient has previously participated in an arthritis self management educational program * Patient is awaiting total hip or total knee replacement surgery patient has a medical co-morbidity that would render the patient to participate fully in the study procedures, including terminal conditions such as chronic obstructive pulmonary disease, end stage renal disease, heart failure, malignancy with anticipated life expectancy of equal to or less than 2 years * Patient has been diagnosed with senile dementia or Alzheimer's disease

Outcomes

Primary Outcomes

A difference in the WOMAC score of 20 percentage points

Secondary Outcomes

A change in health care provider and medication utilization.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.